Health Economics/Outcomes Research, Health Policy, Pharmacoeconomics/Health Economics
GSK (Global Value Evidence and Outcomes department) and Rutgers’ Center for Health Outcomes, Policy and Economics (HOPE) are partnering to offer this exciting two-year fellowship in the highly sought field of Health Economics and Outcomes Research. This program will build a solid foundation in clinical and economic outcomes evaluation, through a combination of hands-on industry experience at GSK (where the fellow will spend the majority of time) and academically-based research at HOPE, working with leaders at both sites. Leadership training, and shadow days at GSK’s Consumer Health and Vaccine sites will also be offered to enhance the learning experience. Graduates will have a strong understanding of the value of pharmaceuticals in global healthcare systems, and will be prepared for positions in the pharmaceutical industry, academia, pharmacy benefit management, or consulting. Coursework towards a Masters of Science in HOPE is a formal component of this program. Competitive stipend, tuition remission, medical and dental insurance, vacation and sick days are provided. Must have a PharmD or PhD degree related to pharmaceutical health services, economics, or administrative sciences.
In recent years there has been a significant focus on healthcare costs, policies, benefits, and comparative effectiveness in relation to improving patient outcomes. The new US healthcare reform bill resulted in an additional 32 million Americans joining the healthcare system in 2014. As a result, there is an increasing need for highly trained professionals who can provide expert analysis and resea...rch in health economics, including patient reported outcomes, economic modeling methodologies, and epidemiology. This need extends across the pharmaceutical industry, among healthcare providers, private payers, and within government agencies.
Research and training in these areas is very limited, with few comprehensive programs throughout the US. Rutgers University, with its premiere health economics research and close geographical proximity to the pharmaceutical and health care industry, is uniquely situated to provide relevant academic programs and research capabilities in health economics and outcomes research.
This new program responds to industry needs and increased demand for trained professionals to conduct research in health economics/outcomes, cost effectiveness, and health policy. Its interdisciplinary curriculum draws on considerable expertise at Rutgers University in economics, data analysis, biostatistics, health policy, and clinical research, and emphasizes the role of pharmaceuticals in the provision of health care. Graduates will have an integrated and comprehensive grounding in health outcomes research, epidemiology, health policy and practice in healthcare